<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="219292">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00229463</url>
  </required_header>
  <id_info>
    <org_study_id>01-10-049</org_study_id>
    <nct_id>NCT00229463</nct_id>
  </id_info>
  <brief_title>Study of Genetic Differences in People With Depression</brief_title>
  <acronym>Genetics</acronym>
  <official_title>Study of Genetic Differences in People With Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify genes involved in depression. Specifically, the
      investigators will analyze some genes that may be related to whether or not a person
      responds to antidepressant medication. This project is part of basic scientific research to
      increase understanding of the role of genetic influences in psychological and mental
      processes involved in the response to treatment for depression.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2002</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Depressive Disorder, Major</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited from previous studies conducted at the Laboratory of Brain,
        Behavior, and Pharmacology, where subjects' response to treatment has already been
        determined. This strategy offers the advantage that no new subjects need to be enrolled in
        placebo-controlled treatment studies.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of Unipolar Major Depression

          -  Control subjects must be healthy normal adults

        Exclusion Criteria:

          -  Subjects with mood symptoms that are not severe enough to qualify for MDD

          -  Subjects with any active medical illness that may be related to ongoing mood disorder

          -  Normal subjects must be free from: a psychiatric diagnosis, substance abuse, a
             history of seizure disorder, and any serious medical illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew F. Leuchter, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA Semel Institute for Neuroscience and Human Behavior</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>November 16, 2016</lastchanged_date>
  <firstreceived_date>September 28, 2005</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Andrew F. Leuchter</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>genetic</keyword>
  <keyword>gene</keyword>
  <keyword>antidepressant</keyword>
  <keyword>research</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
